ad image

In Vitro

1 / 1
Piramal Pharma Solutions
In Vitro Biology

Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site

Piramal Pharma Solutions

PR-M10-23-04Oct 17, 2023
Championing In Vitro Biocompatibility/Biological Reactivity Testing for Plastics Used in Pharma Manufacturing
Biocompatibility

Championing In Vitro Biocompatibility/Biological Reactivity Testing for Plastics Used in Pharma Manufacturing

Janmeet Anant; Monica Cardona

MilliporeSigma

PAO-06-21-CL-09Jun 21, 2021
Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine
Tissue Models

Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine

Liz Boazak, Ph.D.

Altis Biosystems

PAO-03-21-CL-01Mar 11, 2021
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Tissue Models

Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity

Ron Laethem, Ph.D.

Altis Biosystems

PAO-02-21-CL-04Feb 18, 2021
Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro
Tissue Models

Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro

Bailey Zwarycz, Ph.D

Altis Biosystems

PAO-02-21-CL-01Feb 04, 2021
The Power of RepliGut In Vitro Intestinal Stem Cell Models
Tissue Models

The Power of RepliGut In Vitro Intestinal Stem Cell Models

Bailey Zwarycz, Ph.D

Altis Biosystems

PA1081Jan 26, 2021
TARA Biosystems
Drug Discovery

Heart-on-a-Chip Mimics Drug Response Seen in Humans: In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery

TARA Biosystems

PR-M08-19-NI-045Aug 16, 2019
ReportLinker
Market Prediction

In Vitro ADME Testing Services Market, 2019-2030

ReportLinker

PR-M03-19-NI-055Mar 20, 2019
Fucoidans Found in Seaweed Exhibit Promising Anticancer Properties
Drug Development

Fucoidans Found in Seaweed Exhibit Promising Anticancer Properties

Emilie Branch

Pharma's Almanac

PAO-M12-17-NI-025Dec 15, 2017
Modeling Patient-Specific Kidney Diseases by Combining Engineered Stem Cells and Chip Technology
Innovation

Modeling Patient-Specific Kidney Diseases by Combining Engineered Stem Cells and Chip Technology

Emilie Branch

Pharma's Almanac

PAO-M05-17-NI-018May 19, 2017
1 / 1